Financial Information

This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.63
Shares Outstanding35.9M
Average Volume (10 days)982.0K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.70
Sales (TTM)$1.25
Book Value (MRQ)$1.73
Cash Flow (TTM)$0.50
Cash (MRQ)$1.61

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Thomas Sandgaard
President, CEO And Chairman
(638)
Dispose
Aug 7, 2023
Thomas Sandgaard
President, CEO And Chairman
(554)
Dispose
Jul 31, 2023
Thomas Sandgaard
President, CEO And Chairman
6,089
Acquire
Jul 28, 2023
Daniel J. Moorhead
Chief Financial Officer
(1,410)
Dispose
Jul 10, 2023
Thomas Sandgaard
President, CEO And Chairman
(461)
Dispose
Jun 26, 2023

Recent SEC Filings

4
Insider Buy/Sell
Sep 18, 2023
4
Insider Buy/Sell
Sep 18, 2023
4
Insider Buy/Sell
Sep 18, 2023
8-K
Company Events
Sep 11, 2023
4
Insider Buy/Sell
Sep 5, 2023
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.